KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:PHIA • NL0000009538

24.79 EUR
+0.21 (+0.85%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall PHIA gets a fundamental rating of 3 out of 10. We evaluated PHIA against 63 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year PHIA was profitable.
  • PHIA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
  • Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

  • PHIA has a worse Return On Assets (0.63%) than 64.71% of its industry peers.
  • PHIA has a Return On Equity of 1.56%. This is in the lower half of the industry: PHIA underperforms 64.71% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.21%, PHIA is doing worse than 63.24% of the companies in the same industry.
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROIC 4.21%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • PHIA has a worse Profit Margin (0.93%) than 64.71% of its industry peers.
  • Looking at the Operating Margin, with a value of 6.10%, PHIA is doing worse than 61.76% of the companies in the same industry.
  • PHIA's Operating Margin has declined in the last couple of years.
  • PHIA's Gross Margin of 43.49% is on the low side compared to the rest of the industry. PHIA is outperformed by 75.00% of its industry peers.
  • PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
  • Compared to 1 year ago, PHIA has less shares outstanding
  • Compared to 5 years ago, PHIA has more shares outstanding
  • PHIA has a worse debt/assets ratio than last year.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • PHIA has an Altman-Z score of 1.99. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of PHIA (1.99) is comparable to the rest of the industry.
  • The Debt to FCF ratio of PHIA is 14.51, which is on the high side as it means it would take PHIA, 14.51 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 14.51, PHIA is doing worse than 61.76% of the companies in the same industry.
  • PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.69, PHIA is doing worse than 70.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Altman-Z 1.99
ROIC/WACC0.63
WACC6.7%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • PHIA has a Current ratio of 1.32. This is in the lower half of the industry: PHIA underperforms 60.29% of its industry peers.
  • PHIA has a Quick Ratio of 1.32. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.86, PHIA is not doing good in the industry: 66.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
  • PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
  • The Revenue has decreased by -1.43% in the past year.
  • Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

  • PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.28% yearly.
  • Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.75, which indicates a correct valuation of PHIA.
  • Compared to the rest of the industry, the Price/Earnings ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 89.71% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of PHIA to the average of the S&P500 Index (27.93), we can say PHIA is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 16.29, the valuation of PHIA can be described as correct.
  • PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 69.12% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (27.77), we can say PHIA is valued slightly cheaper.
Industry RankSector Rank
PE 16.75
Fwd PE 16.29
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 66.18% of the companies listed in the same industry.
  • PHIA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.3
EV/EBITDA 13.04
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.39
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y7.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KONINKLIJKE PHILIPS NV

AMS:PHIA (2/6/2026, 7:00:00 PM)

24.79

+0.21 (+0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)02-10
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.87B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target27.27 (10%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)-1.13%
PT rev (3m)-0.44%
EPS NQ rev (1m)1.37%
EPS NQ rev (3m)5.07%
EPS NY rev (1m)0.57%
EPS NY rev (3m)4.51%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 16.75
Fwd PE 16.29
P/S 1.34
P/FCF 41.3
P/OCF 19.45
P/B 2.26
P/tB N/A
EV/EBITDA 13.04
EPS(TTM)1.48
EY5.97%
EPS(NY)1.52
Fwd EY6.14%
FCF(TTM)0.6
FCFY2.42%
OCF(TTM)1.27
OCFY5.14%
SpS18.47
BVpS10.96
TBVpS-1.42
PEG (NY)3.39
PEG (5Y)N/A
Graham Number19.1
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROCE 5.61%
ROIC 4.21%
ROICexc 4.21%
ROICexgc 11%
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
FCFM 3.25%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Debt/EBITDA 2.93
Cap/Depr 46.69%
Cap/Sales 3.65%
Interest Coverage 250
Cash Conversion 49.6%
Profit Quality 350.3%
Current Ratio 1.32
Quick Ratio 0.86
Altman-Z 1.99
F-ScoreN/A
WACC6.7%
ROIC/WACC0.63
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 2 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


Can you provide the dividend sustainability for PHIA stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 199.39%.